University of California, San Francisco

University of California, San Francisco

Filtered by:
University of California, San Francisco
19 Sep 2022

Mission Bio

Mission Bio is a US-based biotech company, founded in 2014 as a spinout from the University of San Francisco (UCSF). The company provides genomic sequencing services and devices for use in research.
3 Aug 2022


PrinterPrezz are a US-based end-to-end manufacturer of 3D printed medical devices. IDTechEx spoke with CEO Shri Shetty to discuss the company's mission.
1 Apr 2022

Diabetes Management Technologies 2022-2032: Markets, Players, and Forecasts

IDTechEx Report:
3 Dec 2021

Gut Microbiome Genetically Edited with CRISPR in Mice

In a first, researchers have successfully used the DNA-editing system, CRISPR to alter the genomes of bacteria living in the guts of mammals, a development which stands to advance our understanding of the microbiome and could eventually pave the way for treating gut-related disease.
16 Apr 2021

Tiny Wireless Implant Detects Oxygen Deep Within the Body

Engineers have created a tiny wireless implant that can provide real-time measurements of tissue oxygen levels deep underneath the skin. The device, which is smaller than the average ladybug and powered by ultrasound waves, could help doctors monitor the health of transplanted organs or tissue and provide an early warning of potential transplant failure.
11 Feb 2021


Oura is a Finnish company that have commercialized the Oura Ring, a smart wearable with multiple sensors for health tracking.
3 Feb 2021

Peer-Reviewed Validation of Wireless Earbud for Rheumatoid Arthritis

Nēsos announced the publication of data from a pilot clinical study demonstrating the power of its e-mmunotherapy platform in the treatment of rheumatoid arthritis. The data, published in The Lancet Rheumatology, focuses on a clinical study evaluating the Nēsos developed e-mmunotherapy treatment in a cohort of rheumatoid arthritis patients.
10 Dec 2020

Earbud Treats Rheumatoid Arthritis, Migraines, Postpartum Depression

Imagine a future in which earbuds could harness the power of the brain to regulate immune function and treat diseases like rheumatoid arthritis, depression, and migraine. Such is the ambition of Nēsos, a startup launching out of stealth today, following months of development. The team is pioneering a new method for the treatment of multiple diseases: via an earbud brain interface, proprietary electrical fields are delivered to the target brain areas that help control immune function.
2 Dec 2020

Spotlight Therapeutics $30M Funding for Non-viral CRISPR Gene Editing

Spotlight Therapeutics, Inc., a biotechnology company developing non-viral gene editing therapeutics for direct in vivo editing of target genes, closed its Series A financing bringing the total raised to $30 million.
27 Aug 2020

InkSpace Imaging

InkSpace imaging have applied screen printing of silver nano-particle conductive inks to make lightweight, flexible, low-cost surface coils for MRI (magnetic resonance imaging) scans. They are especially focused on developing smaller coils for pediatric patients.
12 Aug 2020

Non-Invasive Nerve Stimulation Boosts Learning of Foreign Language

New research by neuroscientists revealed that a simple, earbud-like device that imperceptibly stimulates a key nerve leading to the brain could significantly improve the wearer's ability to learn the sounds of a new language. This device may have wide-ranging applications for boosting other kinds of learning as well.
27 Jul 2020

AI in Medical Diagnostics 2020-2030: Image Recognition, Players, Clinical Applications, Forecasts

IDTechEx Report: Dr Nadia Tsao
22 Aug 2019

Reveal Biosensors

IDTechEx was updated on the latest developments and messaging from Reveal Biosensors on their 'Energy Conversion Monitor', a wearable optical sensor which is highly responsive to physiological stress.
13 Aug 2019

Advanced Wound Care Technologies 2020-2030

IDTechEx Report: Dr Nadia Tsao
6 Aug 2019

Brain research decodes thoughts as words instantly

Scientists recently showed that brain activity recorded as research participants spoke could be used to create remarkably realistic synthetic versions of that speech, suggesting hope that one day such brain recordings could be used to restore voices to people who have lost the ability to speak. However, it took the researchers weeks or months to translate brain activity into speech, a far cry from the instant results that would be needed for such a technology to be clinically useful.
21 May 2019

Artificial intelligence tool vastly scales up Alzheimer's research

Researchers have found a way to teach a computer to precisely detect one of the hallmarks of Alzheimer's disease in human brain tissue, delivering a proof of concept for a machine-learning approach to distinguishing critical markers of the disease.
29 Apr 2019

Synthetic speech generated from brain recordings

A state-of-the-art brain-machine interface can generate natural-sounding synthetic speech by using brain activity to control a virtual vocal tract - an anatomically detailed computer simulation including the lips, jaw, tongue and larynx.
20 Feb 2019

CRISPR gene editing makes stem cells 'invisible' to immune system

Scientists have used the CRISPR-Cas9 gene-editing system to create the first pluripotent stem cells that are functionally "invisible" to the immune system, a feat of biological engineering that, in laboratory studies, prevented rejection of stem cell transplants.
18 Jan 2019

3D printed sponge to minimise effects of cancer treatment

With the help of sponges inserted in the bloodstream to absorb excess drugs, doctors are hoping to prevent the dangerous side effects of toxic chemotherapy agents or even deliver higher doses to knock back tumors, like liver cancer, that don't respond to more benign treatments.
21 Nov 2018

Reveal Biosensors

IDTechEx met with Stephen Ursenbach and Guy Hatch, CEO and CTO respectively as well as being co-founders of Reveal Biosensors. They have developed an 'energy conversion monitor' based on a wearable sensor, used in the diagnosis and management of skin tissue hypoxia and linked areas such as sleep disordered breathing (sleep apnea, etc.).